Esketamine Nasal Spray: Innovative Depression Treatment

Key Points About Esketamine Nasal Spray

Esketamine nasal spray is a prescription medication specifically designed to address certain mental health conditions, including treatment-resistant depression and major depressive disorder (MDD). This groundbreaking treatment works by targeting specific brain chemicals to improve mood and alleviate symptoms. Administered as a nasal spray under the supervision of a healthcare provider, esketamine therapy may cause side effects, making it essential to discuss your treatment plan thoroughly with your doctor.

Medication Names: Esketamine and Spravato

US Brand Name: Spravato (Esketamine)

The term “esketamine” refers to the active ingredient in this medication, while “Spravato” is the brand name under which it is marketed. These names are often used interchangeably when discussing this nasal spray as a treatment for depression.

Pharmacologic Category of Esketamine

Esketamine belongs to the following pharmacologic categories:

1. N-methyl-D-aspartate (NMDA) receptor antagonist
2. Antidepressant

Esketamine Nasal Spray Dosing Guidelines

Esketamine therapy is approved for adults with various conditions. It is critical to follow your healthcare provider’s instructions and avoid altering your dose without consulting them first. If you are considering this nasal spray as part of your treatment plan, schedule a telemedicine visit with one of our providers to discuss your options in detail.

Major Depressive Disorder (MDD)

Initial Dose: 56 mg administered intranasally, twice weekly for the first 4 weeks.

Maintenance Dose: 56 mg or 84 mg once weekly during weeks 5–8, then every 1–2 weeks thereafter, depending on your response to treatment.

Treatment-Resistant Depression (TRD)

Initial Dose: 56 mg administered intranasally, twice weekly for the first 4 weeks.

Maintenance Dose: 56 mg or 84 mg once weekly during weeks 5–8, then every 1–2 weeks thereafter, based on your response to the therapy.

Anxiety Disorders

Initial Dose: 56 mg administered intranasally, twice weekly for the first 4 weeks.

Maintenance Dose: 56 mg or 84 mg once weekly during weeks 5–8, then every 1–2 weeks thereafter, depending on your progress.

Post-Traumatic Stress Disorder (PTSD)

Initial Dose: 56 mg administered intranasally, twice weekly for the first 4 weeks.

Maintenance Dose: 56 mg or 84 mg once weekly during weeks 5–8, then every 1–2 weeks thereafter, based on your response to treatment.

Bipolar Disorder

Initial Dose: 56 mg administered intranasally, twice weekly for the first 4 weeks.

Maintenance Dose: 56 mg or 84 mg once weekly during weeks 5–8, then every 1–2 weeks thereafter, depending on your response to the medication.

Obsessive-Compulsive Disorder (OCD)

Initial Dose: 56 mg administered intranasally, twice weekly for the first 4 weeks.

Maintenance Dose: 56 mg or 84 mg once weekly during weeks 5–8, then every 1–2 weeks thereafter, based on your progress.

Chronic Pain

Initial Dose: 56 mg administered intranasally, twice weekly for the first 4 weeks.

Maintenance Dose: 56 mg or 84 mg once weekly during weeks 5–8, then every 1–2 weeks thereafter, depending on your response to the treatment.

Substance Use Disorders

Initial Dose: 56 mg administered intranasally, twice weekly for the first 4 weeks.

Maintenance Dose: 56 mg or 84 mg once weekly during weeks 5–8, then every 1–2 weeks thereafter, based on your progress.

Seasonal Affective Disorder (SAD)

Initial Dose: 56 mg administered intranasally, twice weekly for the first 4 weeks.

Maintenance Dose: 56 mg or 84 mg once weekly during weeks 5–8, then every 1–2 weeks thereafter, depending on your response to the therapy.

Suicidal Ideation

Initial Dose: 84 mg administered intranasally, twice weekly for the first 4 weeks.

Maintenance Dose: 84 mg once weekly during weeks 5–8, then every 1–2 weeks thereafter, based on your progress.

Dosage Forms and Strengths of Esketamine Nasal Spray

Esketamine nasal spray is available in the following forms and strengths:

1. Intranasal spray: 28 mg per spray
2. Available in 56 mg and 84 mg doses

How to Use Esketamine Nasal Spray

Esketamine is administered as a nasal spray under the direct supervision of a healthcare provider. After receiving a dose, you will be monitored for at least two hours to ensure your safety and well-being. It is important to avoid driving or operating heavy machinery for the remainder of the day following treatment. Always follow your doctor’s instructions carefully, and never attempt to use esketamine nasal spray at home without proper medical supervision.

Contraindications for Esketamine Nasal Spray

A contraindication refers to a specific condition or circumstance in which using a medication, such as esketamine nasal spray, could be harmful. If you have any of the following conditions, esketamine treatment may not be appropriate for you. Always consult your healthcare provider before starting any new medication, especially if you have one of the following:

Aneurysmal vascular disease (including in the brain, heart, or other blood vessels): Esketamine nasal spray can elevate blood pressure, which may increase the risk of rupture in individuals with aneurysms.

Uncontrolled high blood pressure: This treatment can cause a temporary rise in blood pressure, which may pose significant risks for individuals with unmanaged hypertension.

History of intracerebral hemorrhage (bleeding in the brain): People with a history of brain hemorrhage may face an increased risk of further bleeding when undergoing esketamine therapy.

Hypersensitivity to esketamine or ketamine: If you have experienced an allergic reaction to esketamine or ketamine in the past, this medication should be avoided.

Pregnancy or breastfeeding (see sections below): Esketamine nasal spray may pose risks to a developing fetus or a breastfeeding infant. Always discuss these risks with your healthcare provider.

Drug-to-Drug Interactions with Esketamine Nasal Spray

Esketamine treatment can interact with other medications, potentially increasing side effects or reducing the effectiveness of either drug. It is essential to inform your healthcare provider about all medications you are currently taking, including over-the-counter drugs and supplements. Known drug interactions include:

1. Benzodiazepines (e.g., Ativan [lorazepam], Valium [diazepam]): These medications may amplify sedation when used alongside esketamine nasal spray.
2. Opioids (e.g., OxyContin [oxycodone], Vicodin [hydrocodone]): Combining opioids with esketamine therapy can heighten the risk of respiratory depression and excessive sedation.
3. Monoamine oxidase inhibitors (MAOIs) (e.g., Nardil [phenelzine], Parnate [tranylcypromine]): These drugs may increase the likelihood of dangerously high blood pressure when taken with esketamine nasal spray.
4. Stimulants (e.g., Adderall [amphetamine], Ritalin [methylphenidate]): Combining stimulants with esketamine for major depressive disorder may raise the risk of elevated blood pressure and heart rate.

Esketamine Nasal Spray During Pregnancy

Is it safe to use esketamine nasal spray during pregnancy?

Esketamine nasal spray is generally not recommended during pregnancy unless the potential benefits clearly outweigh the risks. Research on the effects of esketamine treatment in pregnant women and their developing babies is limited. However, animal studies suggest potential risks, including developmental complications. If you are pregnant or planning to become pregnant, it is crucial to consult your healthcare provider to carefully evaluate the risks and benefits. You may also consider speaking with one of our telemedicine providers for personalized guidance on depression treatment options.

Esketamine Nasal Spray While Breastfeeding

Is it safe to use esketamine nasal spray while breastfeeding?

There is currently insufficient data to determine whether esketamine nasal spray passes into breast milk or its potential effects on a breastfed infant. Due to the possibility of serious side effects in a nursing baby, it is generally advised to avoid esketamine therapy while breastfeeding. If you are breastfeeding or planning to breastfeed, consult your healthcare provider to explore safer alternatives. Our telemedicine providers are available to help you make an informed decision about depression nasal spray therapy.

Estimated Cost of Esketamine Nasal Spray Treatment

The cost of esketamine nasal spray can vary depending on your location and pharmacy. Without insurance, a 30-day supply of Spravato nasal spray (the brand name for esketamine) typically ranges from $590 to $885 when using a GoodRX coupon. For the most accurate pricing, check with your pharmacy and ask your healthcare provider about available financial assistance programs. If you are considering esketamine for treatment-resistant depression, financial planning may play an important role in your decision-making process.

Possible Alternatives to Esketamine Treatment

Depending on your condition, alternative treatments or lifestyle adjustments may help manage your symptoms effectively. It’s important to consult your healthcare provider before making any changes to your treatment plan. Our telemedicine providers are here to support you in exploring these options.

Major Depressive Disorder (MDD): Alternatives include selective serotonin reuptake inhibitors (SSRIs) such as Prozac (fluoxetine) or serotonin-norepinephrine reuptake inhibitors (SNRIs) like Cymbalta (duloxetine). Cognitive-behavioral therapy (CBT) and lifestyle modifications, such as incorporating regular exercise and maintaining a balanced diet, can also play a significant role in managing symptoms. These approaches may complement or, in some cases, serve as alternatives to Esketamine nasal spray for depression.

Treatment-Resistant Depression: For individuals who do not respond to traditional depression treatments, options include electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS), or adding atypical antipsychotics like Abilify (aripiprazole) to the treatment regimen. Esketamine nasal spray is another innovative option specifically designed for treatment-resistant depression and may be worth considering.

Anxiety Disorders: Medications such as SSRIs, including Zoloft (sertraline), or benzodiazepines like Xanax (alprazolam), are commonly prescribed for anxiety. Additionally, mindfulness practices and therapy, such as CBT, can provide significant relief. While Esketamine is primarily approved for depression, exploring anxiety-specific treatments tailored to your needs is essential for effective symptom management.

Post-Traumatic Stress Disorder (PTSD): Common treatment options include SSRIs like Paxil (paroxetine) and trauma-focused therapies such as eye movement desensitization and reprocessing (EMDR). Emerging research is also investigating the potential role of Esketamine therapy in managing PTSD, though more evidence is needed to establish its effectiveness for this condition.

Bipolar Disorder: Mood stabilizers such as Lithobid (lithium) or antipsychotics like Seroquel (quetiapine) are frequently used to manage bipolar disorder. Lifestyle changes, including maintaining a consistent sleep schedule, can also help stabilize mood. While Esketamine nasal spray is not typically used for bipolar disorder, discussing all available treatment options with your healthcare provider is crucial to finding the best approach for your needs.

Obsessive-Compulsive Disorder (OCD): SSRIs like Luvox (fluvoxamine) and cognitive-behavioral therapy (CBT) are standard treatments for OCD. Although Esketamine is not currently a standard treatment for OCD, ongoing research may uncover new possibilities for its use in this area.

Chronic Pain: Non-opioid pain relievers such as Lyrica (pregabalin) or physical therapy are common alternatives for managing chronic pain. Mind-body techniques, including yoga and meditation, may also provide relief. Some studies are exploring the potential use of Esketamine therapy for chronic pain management, though further research is needed.

Substance Use Disorders: Medications like Suboxone (buprenorphine/naloxone) and behavioral therapies such as motivational interviewing have proven effective for treating substance use disorders. While Esketamine nasal spray is not indicated for these conditions, addressing co-occurring issues like depression is an important part of comprehensive care.

Seasonal Affective Disorder (SAD): Light therapy, SSRIs such as Lexapro (escitalopram), and lifestyle changes like spending more time outdoors can help alleviate symptoms of SAD. For individuals with severe symptoms, discussing advanced options, including Esketamine nasal spray for depression, may be beneficial.

Suicidal Ideation: Immediate intervention is critical for anyone experiencing suicidal thoughts. Treatment options may include medications like SSRIs, therapy, and crisis intervention services. If you are struggling with suicidal thoughts, seek help immediately by contacting a healthcare provider or calling emergency services. Esketamine nasal spray has shown promise in reducing suicidal ideation in some cases, making it a potential option for urgent care under medical supervision.

Recent Updates on Esketamine Research

Recent studies have focused on the long-term effects of Esketamine nasal spray, particularly in patients with treatment-resistant depression. Findings suggest that Esketamine may help reduce suicidal ideation in the short term, though further research is needed to confirm its long-term safety and effectiveness. Additionally, ongoing clinical trials are exploring its potential benefits for conditions such as PTSD and chronic pain. Staying informed about the latest research is essential. Be sure to discuss any new findings with your healthcare provider. Our telemedicine providers are also available to help you understand how emerging data may influence your treatment plan.

James Kingsley

Learn More